Peak International Trade Obtain Network Freight Platform Qualification
Release time:
2020-08-17
Jianfeng International Trade has obtained the qualification of online freight platform
, which is the first
in Jinhua and Quzhou. After the interconnection monitoring of Zhejiang provincial transportation department, Jianfeng International Trade Company's online freight platform has passed the online service capability audit, interface access audit, eight capability identification and other audit procedures, on July 2 , , , we successfully obtained the road transport business license with the qualification of "network freight. It is understood that Jianfeng International Trade is currently the first enterprise in Jinhua and Quzhou to obtain this qualification.
Since obtaining the qualification of "car-free carrier" pilot enterprise, Jianfeng International Trade has started to build a network freight platform. Especially since this year, Jianfeng International Trade has obtained the value-added telecom service license in March and December.4 Obtain "Level 3 Equal Insurance" License in April; 5 According to the relevant requirements of Zhejiang Province, the enterprise network freight platform system was reformed in accordance with the "Zhejiang Province Network Freight Information Monitoring System Access Guide" and was officially connected to the Zhejiang Province platform for trial operation that month, 6 25 Complete waybill standard, abnormal rate 0% . has obtained the qualification of network freight platform, which provides more development space for Jianfeng International Trade to promote the transformation of enterprise management, further expand the market, expand the scale and expand the market coverage of transportation business and storage business. At the same time, it also forces enterprises to speed up the transformation of intelligent management and the transformation of storage business and transportation business to intelligent logistics. Relying on the network freight platform, Jianfeng International Trade will fully integrate the existing storage and logistics resources, strive to achieve marketing projects, capacity coordination, service customization, de-intermediation and digitization, and realize the closed-loop operation of the supply chain system PDCA
, thus guiding the return of integrated vehicles and transportation services, and continuously promoting the regional logistics market from low, small and scattered space to resource sharing, value sharing and win-win cooperation. At the same time, the rapid transfer advantages of peak international trade11 square meters warehouse and 1.5 square meters railway station yard can also be better brought into play, changing from traditional storage logistics to innovative logistics transportation modes such as network freight platform, multimodal transportation and digital storage. At present, the peak international trade transportation business is being fully moved to online operation management, to achieve business online, capacity online, transaction online, the whole track monitoring, and to achieve the whole chain of data. The network freight platform has now completed the development of functions such as vehicle track management and monitoring, online verification of vehicle shippers, two-way evaluation of vehicle shippers, capacity pool, online instant payment methods, etc., and its competitiveness is gradually being reflected. (Zhang Zhuoran
Huang Zhiyu)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31